The 24th China Hi-Tech Fair Opens on November 15 in Shenzhen, China
The 24th China Hi-Tech Fair (CHTF 2022) kicked off in Shenzhen on November 15, 2022. Taking place until November 19, this year’s event has been comprehensively upgraded to the largest ever, integrating new product and technology launches, product and solution exhibitions, trade negotiations, and investment finance, across a diverse variety of hi-tech sectors including biomedicine, new materials, modern agriculture, fine chemicals, aerospace, new energy, high-end equipment manufacturing, energy conservation and environmental protection.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221115006208/en/
International Pavilion and IT Exhibition of CHTF 2022 (Photo: Business Wire)
CHTF 2022 will gather a total of 5,000 exhibitors, including domestic multinationals and industry champions such as China General Nuclear Power Corporation, Huawei, ZTE, and Han’s Laser, along with hi-tech “little giants” such as: Kemai, a digital payment system provider; Keanda, a rail transit products manufacturer; and Insighters, a medical technology startup.
Also participating are overseas exhibitors from 38 countries including Brazil, Canada, Finland and Russia, some of which will join via CHTF 2022’s virtual platform. Among them, the Russian Ministry of Education and Technology and the Bavarian State Government of Germany, two of CHTF’s longstanding cooperation partners, have been sending delegations to CHTF for more than 20 consecutive years.
CHTF 2022 will host the inaugural Water Conservation and Innovation Exhibition, which together with a high-tech talent attraction show and an expo for emergency safety will boost the appeal of the event.
Meanwhile, the CHTF Hi-Tech Forum will be held on November 15-17, with a key focus on the digital economy, metaverse, quantum computing, AI, cloud computing, “lighthouse” factories and smart cities, future mobility, and “dual-carbon” goals. The forum will be livestreamed here.
The X-Lake Forum 2022, as the main side-forum of CHTF 2022, was held on November 15. Focused on “openness, integration and future”, this forum discussed development trends and shared cutting-edge hi-tech innovations. John Lee, Chief Executive of the Hong Kong Special Administrative Region; Ho Iat-seng, Chief Executive of the Macao Special Administrative Region; and Ciyong Zou, Director at UNIDO delivered video speeches. Scholars, academicians and renowned industry leaders including Nobel Laureate Roger D. Kornberg delivered keynote speeches at the forum.
More information is available on https://www.chtf.com/english/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221115006208/en/
Contact information
For exhibitor and visitor
Ms. XIE Yan, +8675582848652, selenaxie@chtf.com
Ms. WANG Peggie, +8675582848962, wangyq@chtf.com
Ms. CUI Can, +8675582848764, cathy_cui@chtf.com
Ms. YANG Dan, 86 755 8284 8695, yangd@chtf.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Access Advance Announces Major Growth in Its HEVC and VVC Patent Pools24.11.2025 17:10:00 EET | Press release
Access Advance LLC today announced significant expansions of both its HEVC Advance and VVC Advance Patent Pools during the second and third quarters of 2025, underscoring continued industry confidence in the company's balanced and transparent approach to video codec licensing. This growth follows the successful January 2025 launch of Access Advance's Video Distribution Patent ("VDP") Pool, demonstrating the company's expanding role in comprehensive video codec patent licensing solutions. Among the many highlights, Sharp Corporation joined the HEVC Advance Patent Pool as a Licensor, bringing valuable intellectual property assets to the pool's already extensive patent portfolio. Additionally, Huawei Technologies Co., Ltd., already an HEVC Advance Licensor and Licensee, expanded its collaboration with Access Advance by joining the VVC Advance Patent Pool as a Licensee. HP Inc. also expanded its license to include the VVC Advance Patent Pool after previously joining HEVC Advance in 2024, w
Andersen Global Strengthens Platform in Turkey with Addition of Member Firm24.11.2025 16:30:00 EET | Press release
Andersen Global enhances its presence in Turkey as Celen Corporate Property Valuation & Counseling Inc. becomes Andersen in Turkey, adding breadth to the capabilities provided under the Andersen brand in the country. Founded in 1995 and led by Managing Partner Guniz Celen, the Istanbul-based firm delivers a broad spectrum of services for domestic and international clients. With expertise in real estate corporate finance, tangible and intangible asset valuation, and asset management, Andersen in Turkey delivers solutions that support complex corporate finance decisions to clients in more than 18 countries. “Our mission has always been to provide solutions to the most complex challenges in the real estate and investment sectors,” said Guniz. “Joining the Andersen brand strengthens our capabilities as a trusted advisor and gives us access to global resources, enabling us to create even greater long-term value for our clients.” Global Chairman and CEO of Andersen Mark L. Vorsatz added, “Ce
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland24.11.2025 16:05:00 EET | Press release
Microsize, a leading CDMO specializing in particle size reduction and control technologies, today announced it has signed an agreement to acquire Micro-Macinazione (Mic Mac), a dedicated micronization facility in Monteggio, Switzerland, from Lonza. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124545344/en/ The agreement represents Microsize’s second acquisition from Lonza, following the successful 2022 divestment of its Quakertown, Pennsylvania site. In this transaction, Schedio Group – a Swiss-based provider of jet mills, isolators, spray dryers, and engineering services – is investing alongside Microsize to strengthen and localize its operational base in Europe, advancing a shared vision to lead the next generation of integrated particle engineering solutions. With more than 30 years of experience, Mic Mac has served the pharmaceutical industry with proven GMP-compliant jet milling and micronization capabilities for b
Hytera to Debut S1 E at PMRExpo 202524.11.2025 15:17:00 EET | Press release
Hytera, a leading global provider of critical communications technologies and solutions, today introduced the S1 E, a business-ready, palm-sized two-way radio designed specifically for the retail sector, expanding the portfolio of S Series and providing one more option for retail users to choose for their daily operations. The S1 E will make its debut at PMRExpo, the Europe's premier trade fair for secure, mission- and business-critical communication, taking place from November 25th to 27th, 2025, at Koelnmesse in Cologne, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124768341/en/ Hytera New Released Licence-free Analogue Business Radio S1 E Adhering to the S Series’ signature design language, the S1 E combines a stylish, modern, and minimalist aesthetic with practical functionality. Weighing under 85g, the S1 E provides all-day wearing comfort without tugging or weighing down uniforms. Key enhancements and sta
Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis24.11.2025 15:00:00 EET | Press release
Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for cladribine capsules for the treatment of the rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia Gravis (gMG). In June 2023, the FDA granted Orphan Drug Designation for cladribine capsules for the treatment of gMG. In addition, the Company is actively collaborating with patient organizations and Ad Scientiam, a medical technology company, to support a patient-directed approach to the future management of gMG. If approved, cladribine capsules, currently being studied in the global Phase 3 MyClad trial, could become the first oral treatment for gMG, a rare autoimmune neuromuscular disorder that causes severe muscle weakness and significantly impacts patients’ lives. The FDA’s Fast Track program is designed to facilitate the development and accelerate the review of therapies for serious conditions with unmet medical needs,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom